Catch up with our latest volumes and outcomes data
Below we share recent volumes and clinical outcomes from a sampling of areas in Cleveland Clinic’s Miller Family Heart, Vascular & Thoracic Institute: thoracic surgery, lung transplantation and two unique populations — patients with hypertrophic obstructive cardiomyopathy and patients with pericarditis.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
The following data and ratings are from the Society of Thoracic Surgeons (STS) General Thoracic Surgery Database (3-year period ending December 2022):
Of 103 rated participants in this STS category, Cleveland Clinic was 1 of 15 that achieved a 3-star (highest) rating.
Cleveland Clinic’s Heart, Vascular & Thoracic Institute has a long-established tradition of reporting volume and outcomes data across its various subspecialty areas. For more information like the data reported above, visit clevelandclinic.org/hvtioutcomes and clevelandclinic.org/e15.
Advertisement
Advertisement
Insights on bringing Cleveland Clinic even closer to becoming the best transplant enterprise in the world
Ideation session generates solutions to medication administration errors
Caregivers spearhead changes that improve patient care, shape hospital culture
Potentially cost-effective addition to standard GERD management in post-transplant patients
Findings could help clinicians make more informed decisions about medication recommendations
Consensus statement aims to increase use of the perfusion technology and raise transplant volumes
Initiative generates new ideas for improving efficiency, eliminating waste
Our latest performance data in these areas plus HOCM and pericarditis